全文获取类型
收费全文 | 12287篇 |
免费 | 1349篇 |
国内免费 | 1382篇 |
出版年
2024年 | 33篇 |
2023年 | 154篇 |
2022年 | 407篇 |
2021年 | 670篇 |
2020年 | 549篇 |
2019年 | 598篇 |
2018年 | 610篇 |
2017年 | 481篇 |
2016年 | 615篇 |
2015年 | 857篇 |
2014年 | 952篇 |
2013年 | 967篇 |
2012年 | 1114篇 |
2011年 | 989篇 |
2010年 | 683篇 |
2009年 | 541篇 |
2008年 | 637篇 |
2007年 | 542篇 |
2006年 | 507篇 |
2005年 | 389篇 |
2004年 | 409篇 |
2003年 | 403篇 |
2002年 | 379篇 |
2001年 | 249篇 |
2000年 | 174篇 |
1999年 | 199篇 |
1998年 | 117篇 |
1997年 | 106篇 |
1996年 | 96篇 |
1995年 | 99篇 |
1994年 | 74篇 |
1993年 | 58篇 |
1992年 | 55篇 |
1991年 | 48篇 |
1990年 | 41篇 |
1989年 | 44篇 |
1988年 | 27篇 |
1987年 | 22篇 |
1986年 | 19篇 |
1985年 | 8篇 |
1984年 | 13篇 |
1983年 | 15篇 |
1982年 | 13篇 |
1981年 | 12篇 |
1980年 | 6篇 |
1979年 | 7篇 |
1977年 | 4篇 |
1975年 | 6篇 |
1974年 | 4篇 |
1973年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 325 毫秒
1.
2.
3.
4.
Zhaohua Zhang LiLi Ge Shanshan Zhang Jue Wang Wen Jiang Qian Xin Yun Luan 《Journal of cellular and molecular medicine》2020,24(23):13938
The aim of the study was to explore the mechanism of mesenchymal stem cell‐derived exosomes (MSC‐EXO) to protect against experimentally induced pulmonary hypertension (PH). Monocrotaline (MCT)‐induced rat model of PH was successfully established by a single intraperitoneal injection of 50 mg/kg MCT, 3 weeks later the animals were treated with MSC‐EXO via tail vein injection. Post‐operation, our results showed that MSC‐EXO could significantly reduce right ventricular systolic pressure (RVSP) and the right ventricular hypertrophy index, attenuate pulmonary vascular remodelling and lung fibrosis in vivo. In vitro experiment, the hypoxia models of pulmonary artery endothelial cell (PAEC) and pulmonary vascular smooth muscle cell (PASMC) were used. We found that the expression levels of Wnt5a, Wnt11, BMPR2, BMP4 and BMP9 were increased, but β‐catenin, cyclin D1 and TGF‐β1 were decreased in MSC‐EXO group as compared with MCT or hypoxia group in vivo or vitro. However, these increased could be blocked when cells were transfected with Wnt5a siRNA in vitro. Taken together, these results suggested that the mechanism of MSC‐EXO to prevent PH vascular remodelling may be via regulation of Wnt5a/BMP signalling pathway. 相似文献
5.
Hyperthermic treatment at 43 degrees C suppressed the growth of Ehrlich ascites tumor (EAT) cells in vitro. Incubation of EAT cells at 43 degrees C for as little as 1.5 h totally abolished the transplantability of the tumor. At the same time, the rate of cellular glucose uptake, the density of glucose transporter on the cells as well as the extent of thymidine, uridine and leucine incorporation were significantly reduced. 相似文献
6.
7.
8.
9.
Many studies have verified that microRNAs contribute a lot to neuropathic pain progression. Furthermore, nerve-related inflammatory cytokines play vital roles in neuropathic pain progression. miR-183 has been identified to have a common relationship with multiple pathological diseases. However, the potential effects of miR-183 in the process of neuropathic pain remain undetermined. Therefore, we performed the current study with the purpose of finding the functions of miR-183 in neuropathic pain progression using a chronic sciatic nerve injury (CCI) rat model. We demonstrated that miR-183 expression levels were evidently reduced in CCI rats in contrast with the control group. Overexpression of miR-183 produced significant relief of mechanical hyperalgesia, as well as thermal hyperalgesia in CCI rats. Furthermore, neuropathic pain-correlated inflammatory cytokine expression levels containing interleukin-6 (IL-6) and interleukin-1β (IL-1β), cyclooxygenase-2 (COX-2) were obviously inhibited by upregulation of miR-183. Meanwhile, dual-luciferase reporter assays showed MAP3K4 was a direct downstream gene of miR-183. The expression levels of MAP3K4 were modulated by the increased miR-183 negatively, which lead to the downregulation of IL-6, IL-1β, and COX-2, and then reduced neuropathic pain progression, respectively. Overall, our study pointed out that miR-183 was a part of the negative regulator which could relieve neuropathic pain by targeting MAP3K4. Thus it may provide a new clinical treatment for neuropathic pain patients clinical therapy. 相似文献
10.
Diabetic nephropathy (DN), a major cause of end-stage chronic renal failure, is histologically characterized by glomerulosclerosis. To investigate the molecular mechanisms of DN, it is important to establish a stable model of glomerulosclerosis in mice, because genomic manipulation techniques (such as gene destruction or transgene insertion) are well established in rodent species. In this study, we found that repeated administrations of streptozotocin led to early onset of glomerular sclerotic lesions in C57BL/6 mice, accompanied with renal dysfunction. During the natural course of DN, glomerular endothelial cells decreased at 10 weeks after the start of streptozotocin-injections, whereas myofibroblastic mesangial cells became evident. Our results provide an animal tool to elucidate the molecular mechanisms of DN, for example to investigate vascular pathology in diabetic glomerular diseases. 相似文献